Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

March 2021; Volume 41,Issue 3

Reviews

  • You have access
    T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
    KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES
    Anticancer Research March 2021, 41 (3) 1123-1141; DOI: https://doi.org/10.21873/anticanres.14870
  • You have access
    T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies
    KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES
    Anticancer Research March 2021, 41 (3) 1143-1156; DOI: https://doi.org/10.21873/anticanres.14871
  • You have access
    Tonsillectomy as a Prevention Strategy in the Light of Increasing Incidence of Oropharyngeal Cancer – a Research of Current Literature
    ACHIM M. FRANZEN and JOCHEN P. WINDFUHR
    Anticancer Research March 2021, 41 (3) 1157-1161; DOI: https://doi.org/10.21873/anticanres.14872
  • You have access
    Pre-treatment Apparent Diffusion Coefficient Does Not Predict Therapy Response to Radiochemotherapy in Cervical Cancer: A Systematic Review and Meta-analysis
    HANS-JONAS MEYER, ANDREAS WIENKE and ALEXEY SUROV
    Anticancer Research March 2021, 41 (3) 1163-1170; DOI: https://doi.org/10.21873/anticanres.14873

Experimental Studies

  • You have access
    Biological Activity of a Thiobarbituric Acid Compound in Neuroblastomas
    SANG Y. LEE, BECKY SLAGLE-WEBB, ARUN K. SHARMA and JAMES R. CONNOR
    Anticancer Research March 2021, 41 (3) 1171-1181; DOI: https://doi.org/10.21873/anticanres.14874
  • You have access
    Understanding the Biological Basis of Glioblastoma Patient-derived Spheroids
    KAROLÍNA TURNOVCOVA, DANA MAREKOVA, TOLGA SURSAL, MARKETA KRUPOVA, RONAN GANDHI, PETR KRUPA, RADEK KAISER, VIT HERYNEK, DAVID NETUKA, PAVLA JENDELOVA and MEENA JHANWAR-UNIYAL
    Anticancer Research March 2021, 41 (3) 1183-1195; DOI: https://doi.org/10.21873/anticanres.14875
  • You have access
    Autophagy Induction by α-Santalol in Human Prostate Cancer Cells
    COLE WALTERS, MAVERICK REED, SAMANTHA BARTHOLOMEW and AJAY BOMMAREDDY
    Anticancer Research March 2021, 41 (3) 1197-1202; DOI: https://doi.org/10.21873/anticanres.14876
  • You have access
    The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver Tissue
    JUN AKIBA, TAKAFUMI YOSHIDA, EIJI SADASHIMA, KAZUYA MURATA, TAKANORI MATSUI, SHO-ICHI YAMAGISHI, HIRONORI KUSANO, YUTARO MIHARA, SHINJI MIZUOCHI, YOSHINAO KINJOU, YOSHIKI NAITO, TORU HISAKA, HISAMUNE SAKAI, KOJI OKUDA, OSAMU NAKASHIMA and HIROHISA YANO
    Anticancer Research March 2021, 41 (3) 1203-1212; DOI: https://doi.org/10.21873/anticanres.14877
  • You have access
    The Anti-oxidant Monoterpene p-Cymene Reduced the Occurrence of Colorectal Cancer in a Hyperlipidemia Rat Model by Reducing Oxidative Stress and Expression of Inflammatory Cytokines
    SHUIMING WANG, XIAOFENG WANG, YU WANG, QIANG LENG, YU SUN, ROBERT M. HOFFMAN and HEIYING JIN
    Anticancer Research March 2021, 41 (3) 1213-1218; DOI: https://doi.org/10.21873/anticanres.14878
  • You have access
    CD105 (Endoglin): A Potential Anticancer Therapeutic Inhibits Mitogenesis and Map Kinase Pathway Activation
    DONGHUI LIU, SHANT KUMAR, JASON ASHWORTH, KAMELA ALI, ABDULMANNAN FADEL, BAOQIANG GUO and MARK SLEVIN
    Anticancer Research March 2021, 41 (3) 1219-1229; DOI: https://doi.org/10.21873/anticanres.14879
  • You have access
    CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer
    SEBASTIAN GRIESING, BIN-CHI LIAO and JAMES CHIH-HSIN YANG
    Anticancer Research March 2021, 41 (3) 1231-1242; DOI: https://doi.org/10.21873/anticanres.14880
  • You have access
    The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells
    SLAVOMIR KRAJNAK, AMELIE LOEWE, MARCO JOHANNES BATTISTA, ANNETTE HASENBURG, ANNE-SOPHIE HEIMES, MARCUS SCHMIDT, ROXANA SCHWAB and WALBURGIS BRENNER
    Anticancer Research March 2021, 41 (3) 1243-1250; DOI: https://doi.org/10.21873/anticanres.14881
  • You have access
    Sorafenib Induces Apoptosis and Inhibits NF-κB-mediated Anti-apoptotic and Metastatic Potential in Osteosarcoma Cells
    CHING-HSUAN WU, KUNG-HUNG LIN, BO-SIANG FU, FEI-TING HSU, JAI-JEN TSAI, MAO-CHI WENG and PO-JUNG PAN
    Anticancer Research March 2021, 41 (3) 1251-1259; DOI: https://doi.org/10.21873/anticanres.14882
  • You have access
    Erlotinib Activates Different Cell Death Pathways in EGFR-mutant Lung Cancer Cells Grown in 3D Versus 2D Culture Systems
    HYUN-KYUNG LEE, MIN HYE NOH, SEUNG-WOO HONG, SEUNG-MI KIM, SUNG HYUN KIM, YEONG SEOK KIM, V. COURTNEY BROADDUS and DAE YOUNG HUR
    Anticancer Research March 2021, 41 (3) 1261-1269; DOI: https://doi.org/10.21873/anticanres.14883
  • You have access
    Synergistic Effect of Apigenin and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells
    SERA KAYACAN, KAAN YILANCIOGLU, AYSE SEDA AKDEMIR, FATMA KAYA-DAGISTANLI, GULAY MELIKOGLU and MELEK OZTURK
    Anticancer Research March 2021, 41 (3) 1271-1282; DOI: https://doi.org/10.21873/anticanres.14884
  • You have access
    Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells
    YUSUKE ASADA, MASASHI TSURUTA, KOJI OKABAYASHI, KOHEI SHIGETA, TAKASHI ISHIDA, TAKEHIRO SHIMADA, HIROFUMI SUZUMURA, KAORU KOISHIKAWA, SHINGO AKIMOTO, HIROTOSHI HASEGAWA and YUKO KITAGAWA
    Anticancer Research March 2021, 41 (3) 1283-1290; DOI: https://doi.org/10.21873/anticanres.14885
  • You have access
    Tumor Cell Microenvironment and Microvessel Density Analysis in MALT Type Lymphoma
    ROBERTO TAMMA, GIUSEPPE INGRAVALLO, TIZIANA ANNESE, MICHELA DE GIORGIS, FABRIZIA DI GIOVANNI, FRANCESCO GAUDIO, TOMMASINA PERRONE, PELLEGRINO MUSTO, GIORGINA SPECCHIA and DOMENICO RIBATTI
    Anticancer Research March 2021, 41 (3) 1291-1297; DOI: https://doi.org/10.21873/anticanres.14886
  • You have access
    Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated ApcMin/+ Mice
    MASARU TERASAKI, TAKAHIRO HAMOYA, ATSUHITO KUBOTA, HIROYUKI KOJIMA, TAKUJI TANAKA, HAYATO MAEDA, KAZUO MIYASHITA and MICHIHIRO MUTOH
    Anticancer Research March 2021, 41 (3) 1299-1305; DOI: https://doi.org/10.21873/anticanres.14887
  • You have access
    Gene Deletion of Microsomal Prostaglandin E Synthase-1 Suppresses Chemically Induced Skin Carcinogenesis
    YUKA SASAKI, HIROSHI KUWATA, ERI AIDA, TSUBASA OCHIAI, DAISUKE KAMEI, YOSHIHITO NAKATANI and SHUNTARO HARA
    Anticancer Research March 2021, 41 (3) 1307-1314; DOI: https://doi.org/10.21873/anticanres.14888
  • You have access
    Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression
    SO-YOUNG PARK, YU-RI SEO, MIN JI KO, JAE-HO LEE, KYUNG-SOO CHUN, MIN-JI KIM, YOUNG-KUG CHOO, TAE-JIN LEE and YUN-HAN LEE
    Anticancer Research March 2021, 41 (3) 1315-1325; DOI: https://doi.org/10.21873/anticanres.14889
  • You have access
    Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer
    AYA TOKUDA, TORU MIYAKE, DAIKI YASUKAWA, DAIJI IKUTA, KEN-ICHI MUKAISHO, SATOSHI MURATA, TOMOHARU SHIMIZU and MASAJI TANI
    Anticancer Research March 2021, 41 (3) 1327-1339; DOI: https://doi.org/10.21873/anticanres.14890
  • You have access
    Robustness of a Cancer Profiling Test Using Formalin-fixed Paraffin Embedded Tumor Specimens
    SHIN ITO, IKURO SATO, MAI MOCHIZUKI, KAZUNORI YAMAGUCHI, KEIICHI TAMAI, TAKAMICHI MINATO, NOBUHIRO TANUMA, HIROSHI SHIMA and JUN YASUDA
    Anticancer Research March 2021, 41 (3) 1341-1348; DOI: https://doi.org/10.21873/anticanres.14891
  • You have access
    Annexin A10 Expression Is Associated With Poor Prognosis in Small Bowel Adenocarcinoma
    AKIRA ISHIKAWA, KAZUYA KURAOKA, JUNICHI ZAITSU, AKIHISA SAITO, TOSHIO KUWAI, YOSUKE SHIMIZU, TAKESHI SUDO, HIROTAKA TASHIRO, KIYOMI TANIYAMA and WATARU YASUI
    Anticancer Research March 2021, 41 (3) 1349-1355; DOI: https://doi.org/10.21873/anticanres.14892
  • You have access
    Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells
    WEI-TING CHEN, CHENG-HSIEN CHEN, HUNG-TAI SU, PO-FU YUEH, FEI-TING HSU and I-TSANG CHIANG
    Anticancer Research March 2021, 41 (3) 1357-1364; DOI: https://doi.org/10.21873/anticanres.14893
  • You have access
    Calorie Restriction Suppresses the Progression of Radiation-Induced Intestinal Tumours in C3B6F1 ApcMin/+ Mice
    TAKAMITSU MORIOKA, SHUNSUKE YAMAZAKI, HIROMI YANAGIHARA, MASAAKI SUNAOSHI, MUTSUMI KAMINISHI and SHIZUKO KAKINUMA
    Anticancer Research March 2021, 41 (3) 1365-1375; DOI: https://doi.org/10.21873/anticanres.14894
  • You have access
    Expression Patterns of ERα, ERβ, AR, SIRT1, SIRT2, and SIRT3 in Prostate Cancer Tissue and Normal Prostate Tissue
    JAE HWI CHOI, SEE MIN CHOI, SIN WOO LEE, SEONG UK JEH, JAE SEOG HYUN, MIN HO LEE, CHUNWOO LEE, SUNG CHUL KAM, DONG CHUL KIM, JONG SIL LEE and JEONG SEOK HWA
    Anticancer Research March 2021, 41 (3) 1377-1386; DOI: https://doi.org/10.21873/anticanres.14895
  • You have access
    Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells
    YOUNGKI LEE and DEOKBAE PARK
    Anticancer Research March 2021, 41 (3) 1387-1399; DOI: https://doi.org/10.21873/anticanres.14896
  • You have access
    Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26
    EGLE ZALYTE, VERONIKA DEDONYTE, BENEDIKTAS KURLINKUS, AUDRIUS SILEIKIS, PETER SCHEMMER and MINDAUGAS VALIUS
    Anticancer Research March 2021, 41 (3) 1401-1406; DOI: https://doi.org/10.21873/anticanres.14897
  • You have access
    470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway
    SANGJOON MO, HYUN JEONG KU, SUN-HYANG CHOI, HYE JUNG JEONG, DONG-GUK PARK, MAN HWAN OH and JIN CHUL AHN
    Anticancer Research March 2021, 41 (3) 1407-1420; DOI: https://doi.org/10.21873/anticanres.14898
  • You have access
    The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients
    SARA PĄCZEK, MARTA ŁUKASZEWICZ-ZAJĄC, MARIUSZ GRYKO, AGNIESZKA KULCZYŃSKA-PRZYBIK and BARBARA MROCZKO
    Anticancer Research March 2021, 41 (3) 1421-1428; DOI: https://doi.org/10.21873/anticanres.14899
  • You have access
    Bioreductive Activation of Antitumour Drugs, Doxorubicin and Pirarubicin, Does Not Affect Their Ability to Induce Apoptosis of Sensitive and Multidrug Resistant Leukaemia HL60 Cells
    DOROTA KOSTRZEWA-NOWAK and JOLANTA TARASIUK
    Anticancer Research March 2021, 41 (3) 1429-1438; DOI: https://doi.org/10.21873/anticanres.14900

Clinical Studies

  • You have access
    Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis
    URSULA M. FINDLEN, REBECCA L. BELT, LING FAN, NIKIA BRIDGES, JASON A. BENEDICT and STEVEN H. ERDMAN
    Anticancer Research March 2021, 41 (3) 1439-1444; DOI: https://doi.org/10.21873/anticanres.14901
  • You have access
    Staged Stereotactic Radiosurgery Decreases Symptomatic Radionecrosis in Large Brain Metastasis
    NEIL CHEVLI, HUI-CHUAN WANG, PRACHI DUBEY, WAQAR HAQUE, ANDREW M. FARACH, RAMIRO PINO, ROBERT C. ROSTOMILY, E. BRIAN BUTLER and BIN S. TEH
    Anticancer Research March 2021, 41 (3) 1445-1449; DOI: https://doi.org/10.21873/anticanres.14902
  • You have access
    Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases
    REGINE MARIETTE PERL, JOHANNES PORTUGALL, CLEMENS HINTERLEITNER, MARTINA HINTERLEITNER, CHRISTOPHER KLOTH, SVEN STEPHAN WALTER, MICHAEL BITZER and MARIUS STEFAN HORGER
    Anticancer Research March 2021, 41 (3) 1451-1458; DOI: https://doi.org/10.21873/anticanres.14903
  • You have access
    A Diagnostic Score (DS) Is a Powerful Tool in Diagnosis of Acute Appendicitis in Elderly Patients With Acute Abdominal Pain
    MAARET ESKELINEN, JANNICA MEKLIN, KARI SYRJÄNEN and MATTI ESKELINEN
    Anticancer Research March 2021, 41 (3) 1459-1469; DOI: https://doi.org/10.21873/anticanres.14904
  • You have access
    Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases
    CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA
    Anticancer Research March 2021, 41 (3) 1471-1474; DOI: https://doi.org/10.21873/anticanres.14905
  • You have access
    MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53
    XIAOCHEN ZHANG, YOSHIYUKI YAMAMOTO, XIAOXUAN WANG, MASASHI SATO, MAMIKO IMANISHI, AKINORI SUGAYA, MITSUAKI HIROSE, SHINJI ENDO, TOSHIKAZU MORIWAKI, KENJI YAMATO and ICHINOSUKE HYODO
    Anticancer Research March 2021, 41 (3) 1475-1483; DOI: https://doi.org/10.21873/anticanres.14906
  • You have access
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
    MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
  • You have access
    Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer
    NORIAKI ITO, TAKESHI MASUDA, TAKU NAKASHIMA, SATOSHI NAKAO, KAKUHIRO YAMAGUCHI, SHINJIRO SAKAMOTO, YASUSHI HORIMASU, SHINTARO MIYAMOTO, HIROSHI IWAMOTO, KAZUNORI FUJITAKA, HIRONOBU HAMADA and NOBORU HATTORI
    Anticancer Research March 2021, 41 (3) 1497-1506; DOI: https://doi.org/10.21873/anticanres.14908
  • You have access
    Resistance to Preoperative Oral Care Is Associated With Postoperative Pneumonia After Oesophageal Cancer Surgery
    KENGO KURIYAMA, MAKOTO SOHDA, TAKAYOSHI WATANABE, HIDEYUKI SAITO, TOMONORI YOSHIDA, KEIGO HARA, MAKOTO SAKAI, MAI KIM, TAKUYA ASAMI, SATOSHI YOKOO, HIROYUKI KUWANO, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research March 2021, 41 (3) 1507-1514; DOI: https://doi.org/10.21873/anticanres.14909
  • You have access
    Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon
    CARLOS A. RUBIO and PETER T. SCHMIDT
    Anticancer Research March 2021, 41 (3) 1515-1521; DOI: https://doi.org/10.21873/anticanres.14910
  • You have access
    Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer
    EVANGELOS DIMAKAKOS, KONSTANTINOS LIVANIOS, IOANNIS VATHIOTIS, GEORGIA GOMATOU, IOANNIS GKIOZOS, ELIAS KOTTEAS, ELIAS KAINIS and KONSTANTINOS SYRIGOS
    Anticancer Research March 2021, 41 (3) 1523-1528; DOI: https://doi.org/10.21873/anticanres.14911
  • You have access
    Anatomical Predictors of Dosimetric Advantages for Deep-inspiration-breath-hold 3D-conformal Radiotherapy Among Women With Left Breast Cancer
    GIANLUCA FERINI, LAURA MOLINO, ANTONELLA TRIPOLI, VITO VALENTI, SALVATORE IVAN ILLARI, VALENTINA ANNA MARCHESE, IRENE RITA CRAVAGNO and GIUSEPPINA RITA BORZI
    Anticancer Research March 2021, 41 (3) 1529-1538; DOI: https://doi.org/10.21873/anticanres.14912
  • You have access
    Site-specific Response to Nivolumab in Renal Cell Carcinoma
    TAKAHITO NEGISHI, NOBUKI FURUBAYASHI, TOHRU NAKAGAWA, NAOTAKA NISHIYAMA, HIROSHI KITAMURA, YOSHIFUMI HORI, KENTAROU KUROIWA, YUHYON SON, NARIHITO SEKI, TOSHIHISA TOMODA, EIJIRO OKAJIMA and MOTONOBU NAKAMURA
    Anticancer Research March 2021, 41 (3) 1539-1545; DOI: https://doi.org/10.21873/anticanres.14913
  • You have access
    Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy
    SATORU FURUHASHI, YOSHIFUMI MORITA, SHINYA IDA, RYUTA MURAKI, RYO KITAJIMA, KATSUNORI SUZUKI, MAKOTO TAKEDA, HIROTOSHI KIKUCHI, YOSHIHIRO HIRAMATSU, KIYOTAKA KURACHI, YOJI SHIDO, KEN SUGIMOTO, HIROAKI ITO, YUICHIRO MAEKAWA, HIROYUKI MINETA, HIDEAKI MIYAKE and HIROYA TAKEUCHI
    Anticancer Research March 2021, 41 (3) 1547-1553; DOI: https://doi.org/10.21873/anticanres.14914
  • You have access
    Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry
    CHARLES MARCHAND-CRETY, MADELINE PASCARD, ADELINE DEBREUVE-THERESETTE, LEILA ETTALHAOUI, CLAIRE SCHVARTZ, MOHAMAD ZALZALI, MATHIAS BRUGEL, SARA BELLEFQIH and STÉPHANIE SERVAGI-VERNAT
    Anticancer Research March 2021, 41 (3) 1555-1561; DOI: https://doi.org/10.21873/anticanres.14915
  • You have access
    NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis
    YUKI HIROSE, JUN SAKATA, TAKASHI KOBAYASHI, KOHEI MIURA, KIZUKI YUZA, MAE NAKANO, HIROSHI ICHIKAWA, MASAYUKI NAGAHASHI, YOSHIFUMI SHIMADA, HITOSHI KAMEYAMA and TOSHIFUMI WAKAI
    Anticancer Research March 2021, 41 (3) 1563-1570; DOI: https://doi.org/10.21873/anticanres.14916
  • You have access
    Pathological Complete Remission of Liver Metastases Correlates With Elimination of Tumor-infiltrating Tregs in Gastric Cancer
    YASUTAKA NAKANISHI, SEIICHI HIROTA, YUDAI HOJO, TATSURO NAKAMURA, TSUTOMU KUMAMOTO, YASUNORI KURAHASHI, YOSHINORI ISHIDA and HISASHI SHINOHARA
    Anticancer Research March 2021, 41 (3) 1571-1577; DOI: https://doi.org/10.21873/anticanres.14917
  • You have access
    Prominent Papillary Growth Pattern and Severe Nuclear Pleomorphism Induced by Neoadjuvant Chemotherapy in Ovarian Mucinous Carcinoma: Potential for Misdiagnosis as High-grade Serous Carcinoma
    HEE JUNG KWON, SANG YONG SONG and HYUN-SOO KIM
    Anticancer Research March 2021, 41 (3) 1579-1586; DOI: https://doi.org/10.21873/anticanres.14918
  • You have access
    Radiotherapy as Part of Treatment Strategies in Nasal Cavity and Paranasal Sinus Malignancies
    NORA OWIN, KHALED ELSAYAD, DANIEL ROLF, UWE HAVERKAMP, DOMINIK SUWELACK, ROBERT TSCHAKERT, HENDRIK BERSSENBRUGGE, JOHANNES KLEINHEINZ, CLAUDIA RUDACK and HANS THEODOR EICH
    Anticancer Research March 2021, 41 (3) 1587-1592; DOI: https://doi.org/10.21873/anticanres.14919
  • You have access
    A High Postoperative Serum C-reactive Protein Level Has a Negative Impact on Long-term Survival, Regardless of Postoperative Infectious Complications, in Patients Who Undergo Laparoscopic Surgery for Colorectal Cancer
    MASATSUNE SHIBUTANI, WANG EN, YUKI OKAZAKI, KIYOSHI MAEDA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research March 2021, 41 (3) 1593-1598; DOI: https://doi.org/10.21873/anticanres.14920
  • You have access
    Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
    YOSHIFUMI KADONO, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, TAIKI KAMIJIMA, CHIKASHI SETO, AKINOBU TAKANO, SATOSHI YOTSUYANAGI, RYUNOSUKE NAKAGAWA, TOHRU MIYAGI, SHUHEI AOYAMA, HIDEKI ASAHI, RIE FUKUDA and ATSUSHI MIZOKAMI
    Anticancer Research March 2021, 41 (3) 1599-1606; DOI: https://doi.org/10.21873/anticanres.14921
  • You have access
    Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy
    YUDAI ISHIYAMA, TSUNENORI KONDO, YUKI NEMOTO, YUKI KOBARI, HIROKI ISHIHARA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, YASUNOBU HASHIMOTO, TOSHIO TAKAGI, JUNPEI IIZUKA and KAZUNARI TANABE
    Anticancer Research March 2021, 41 (3) 1607-1614; DOI: https://doi.org/10.21873/anticanres.14922
  • You have access
    Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy
    YUKINA SATO, HIROTOSHI IIHARA, MOTOHIKO KINOMURA, CHIEMI HIROSE, HIRONORI FUJII, JUNKI ENDO, KOMEI YANASE, DAIZO KAITO, YUKA SASAKI, TAKENOBU GOMYO, CHIZURU SAKAI, MASAMICHI IWAI, YOSHIKI TSUBOI, TAKUMA ISHIHARA, RYO KOBAYASHI, YASUSHI OHNO and AKIO SUZUKI
    Anticancer Research March 2021, 41 (3) 1615-1620; DOI: https://doi.org/10.21873/anticanres.14923
  • You have access
    Prognostic Impact of Albumin-bilirubin (ALBI) Grade on Non-small Lung Cell Carcinoma: A Propensity-score Matched Analysis
    FUMIHIKO KINOSHITA, TAKANORI YAMASHITA, YUKA OKU, KEISUKE KOSAI, YUKI ONO, SHO WAKASU, NAOKI HARATAKE, GOUJI TOYOKAWA, TOMOYOSHI TAKENAKA, TETSUZO TAGAWA, MOTOTSUGU SHIMOKAWA, NAOKI NAKASHIMA and MASAKI MORI
    Anticancer Research March 2021, 41 (3) 1621-1628; DOI: https://doi.org/10.21873/anticanres.14924
  • You have access
    Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma
    SHOZO MORI, TAKU AOKI, YUHKI SAKURAOKA, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUKIHIRO ISO and KEIICHI KUBOTA
    Anticancer Research March 2021, 41 (3) 1629-1639; DOI: https://doi.org/10.21873/anticanres.14925
  • You have access
    Acute Kidney Injury Following Hyperthermic Intraperitoneal Chemotherapy With Cisplatin
    KERRY L. CHEN, RAPHAEL SHAMAVONIAN, JOSH B. KARPES, NAYEF A. ALZAHRANI and DAVID L. MORRIS
    Anticancer Research March 2021, 41 (3) 1641-1646; DOI: https://doi.org/10.21873/anticanres.14926
  • You have access
    Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma
    MITSUTAKE YANO, MARIKO MIYAZAWA, NAOKI OGANE, AIKO OGASAWARA, KOSEI HASEGAWA, HISASHI NARAHARA and MASANORI YASUDA
    Anticancer Research March 2021, 41 (3) 1647-1654; DOI: https://doi.org/10.21873/anticanres.14927
  • You have access
    Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients
    TOMONORI HIRASHIMA, YOSHIMI NODA, HIDEKAZU SUZUKI, SHINGO NASU, AYAKO TANAKA, NAOKO MORISHITA, NORIKO RYOTA, KAORI IWATA, YUKARI OKADA and NORIO OKAMOTO
    Anticancer Research March 2021, 41 (3) 1655-1662; DOI: https://doi.org/10.21873/anticanres.14928
  • You have access
    Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms
    KEISHI SUGIMACHI, YOHEI MANO, YOSHIHIRO MATSUMOTO, TOMONORI NAKANOKO, HIDEO UEHARA, YUICHIRO NAKASHIMA, MASAHIKO SUGIYAMA, MITSUHIKO OTA, MASARU MORITA and YASUSHI TOH
    Anticancer Research March 2021, 41 (3) 1663-1669; DOI: https://doi.org/10.21873/anticanres.14929
  • You have access
    First-line Gemcitabine Versus Treatment of Physician’s Choice for Metastatic Breast Cancer: A Prospective Cohort Study
    SHINYA YAMAMOTO, KAZUTAKA NARUI, TAKASHI ISHIKAWA, SHOKO ADACHI, KAZUHIRO SHIMADA, DAISUKE SHIMIZU, AKIMITSU YAMADA, SADATOSHI SUGAE, MIKIKO TANABE, MARI OBA, SATOSHI MORITA, TAKAKO DOI, SATOSHI HASEGAWA, TOMOYUKI MORITA, AYAKO KITO, TAKASHI CHISHIMA, YASUSHI ICHIKAWA and ITARU ENDO
    Anticancer Research March 2021, 41 (3) 1671-1676; DOI: https://doi.org/10.21873/anticanres.14930
  • You have access
    Feasibility and Safety of Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Elderly Patients With Locally Advanced Rectal Cancer
    KYOSUKE AGAWA, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, GOSUKE TAKIGUCHI, NAOKI URAKAWA, SHINGO KANAJI, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI and YOSHIHIRO KAKEJI
    Anticancer Research March 2021, 41 (3) 1677-1682; DOI: https://doi.org/10.21873/anticanres.14931
  • You have access
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
    NAOKI FUKUDA, KAZUHISA TODA, AKIHIRO OHMOTO, XIAOFEI WANG, NAOMI HAYASHI, TETSUYA URASAKI, YASUYOSHI SATO, KENJI NAKANO, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI
    Anticancer Research March 2021, 41 (3) 1683-1691; DOI: https://doi.org/10.21873/anticanres.14932
  • You have access
    Complete Response of Bone Metastasis in Non-small Cell Lung Cancer With Pembrolizumab: Two Case Reports
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, HIROTAKA YONEZAWA, YOSHIHIRO ARAKI, SEI MORINAGA, KAZUO KASAHARA, TAKASHI SONE and HIROYUKI TSUCHIYA
    Anticancer Research March 2021, 41 (3) 1693-1699; DOI: https://doi.org/10.21873/anticanres.14933
  • You have access
    Impact of the Regional Palliative Care Pathway on Emergency Room Visits and Hospitalizations
    OLLI HALTIA, OUTI M. HIRVONEN, TIINA SAARTO and JUHO T. LEHTO
    Anticancer Research March 2021, 41 (3) 1701-1706; DOI: https://doi.org/10.21873/anticanres.14934
  • You have access
    Drug-induced Interstitial Lung Disease Has the Same Degree of Risk for Mortality as Old Age in Patients With Lung Cancer
    KOHEI IWASHITA, TOMOHIRO MIZUNO, SATOMI KUMAZAWA, KAZUYOSHI IMAIZUMI and SHIGEKI YAMADA
    Anticancer Research March 2021, 41 (3) 1707-1711; DOI: https://doi.org/10.21873/anticanres.14935

Erratum

  • You have access
    Erratum
    Anticancer Research March 2021, 41 (3) 1713; DOI: https://doi.org/10.21873/anticanres.41.3.1713
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 41, Issue 3
March 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Biological Activity of a Thiobarbituric Acid Compound in Neuroblastomas
  • Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis
  • CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer
  • The Anti-oxidant Monoterpene p-Cymene Reduced the Occurrence of Colorectal Cancer in a Hyperlipidemia Rat Model by Reducing Oxidative Stress and Expression of Inflammatory Cytokines
  • Autophagy Induction by α-Santalol in Human Prostate Cancer Cells
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Erratum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire